[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569548":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":45,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":64,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":71,"overallStatus":74,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Aydin Adnan Menderes University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients on Lurasidone",null,"Patient who are admitted by the psychiatry clinic of our center and meet the inclusion criteria",[13],"Diagnostic Test: Global Longitudinal Strain",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Global Longitudinal Strain","Global longitudinal strain measurement is a more objective method to determine left ventricular systolic function than traditional eyeballing method. It helps to detect and quantify subtle changes even so it is an emerging method to evaluate the cardiotoxicity of chemotherapeutic drugs. It is planned to compare each selected patient's GLS measurement before starting to use lurasidone and after six months of using it. Hereby our aim is to find if lurasidone has any effect on left ventricular systolic function.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Sevil Gulasti Cardiologist Sevil Gulasti","CONTACT","+905054513277","drsevilonay@hotmail.com",[27],{"facility":28,"status":10,"city":29,"state":30,"zip":31,"country":32,"countryCode":10,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Adnan Menderes University","Aydin","Zafer","9010","Turkey (Türkiye)",{"type":34,"coordinates":35},"Point",[36,37],27.83963,37.84501,{"lat":37,"lon":36},[40,42],{"name":41,"role":23,"phone":24,"phoneExt":10,"email":25},"Sevil Gulasti",{"name":43,"role":23,"phone":44,"phoneExt":10,"email":10},"Maide Gizem Cevik","+905348223574",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Sevil Gulastı","Cardiologist","100569548","effects-of-lurasidone-on-left-ventricle-systolic-functions-100569548",false,"NCT06695676","Effects of Lurasidone on Left Ventricle Systolic Functions","Evaluation of Left Ventricle Systolic Functions of Patients On Lurasidone","Lurasidone","Inclusion Criteria:\n\n* Aged 18 to 65 years\n* Diagnosed with schizophrenia or bipolar disorder by the psychiatry clinic of our center and indicated to use lurasidone molecule\n* Hasn't been diagnosed with coronary artery disease, any kind of heart failure or severe valvular disease\n\nExclusion Criteria:\n\n* Patients who do not agree to participate to the trial\n* Patient who do not meet the inclusion criteria",true,"ALL","18 Years","65 Years",{"count":62,"type":63},62,"ESTIMATED","6 Months","OBSERVATIONAL","The goal of our study to learn if lurasidone molecule which is used on patients with schizophrenia or bipolar disorder has any cardiotoxic effect.",[68,69,70],"Lurasidone Cardiotoxicity","Schizophrenia Patients","Bipolar Disorders",[17,72,55,73],"Cardiotoxicity","antipsychotic drugs","NOT_YET_RECRUITING","2024-11-17",{"date":77,"type":78},"2024-11-19","ACTUAL",{"date":80,"type":63},"2024-11",{"date":82,"type":63},"2025-06-01",{"name":5,"class":6},1]